These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29621514)

  • 1. Pretreatment Lesions on Magnetic Resonance Imaging in Patients With Hepatitis C Virus Infection Diagnosed With Hepatocellular Carcinoma After Initiating Direct-Acting Antiviral Therapy.
    Scott RA; Aithal GP; Francis ST; Irving WL
    Gastroenterology; 2018 May; 154(6):1848-1850. PubMed ID: 29621514
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.
    Ooka Y; Miho K; Shuntaro O; Nakamura M; Ogasawara S; Suzuki E; Yasui S; Chiba T; Arai M; Kanda T; Maruyama H; Yokosuka O; Kato N; Mochizuki H; Omata M
    Hepatol Int; 2018 Nov; 12(6):523-530. PubMed ID: 30242733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
    Brechot C
    Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
    Wirth TC; Manns MP
    Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic hepatitis C virus and direct-acting antivirals: economic implications for hepatocellular carcinoma in Medicaid beneficiaries with cirrhosis.
    Mantravadi S
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP180-SP184. PubMed ID: 28665676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C-related hepatocellular carcinoma and the treatment with direct-acting antiviral agents].
    Liu X; Gao YH; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):944-947. PubMed ID: 29325299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma.
    Kamp WM; Sellers CM; Stein S; Lim JK; Kim HS
    J Vasc Interv Radiol; 2020 Jun; 31(6):953-960. PubMed ID: 32376182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma.
    Baumert TF; Hoshida Y
    Viruses; 2019 May; 11(5):. PubMed ID: 31096600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Achievement of a Sustained Virological Response Either Before or After Hepatectomy Improves the Prognosis of Patients with Primary Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    Ann Surg Oncol; 2019 Dec; 26(13):4566-4575. PubMed ID: 31602577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Ravi S; Axley P; Jones D; Kodali S; Simpson H; McGuire BM; Singal AK
    Gastroenterology; 2017 Mar; 152(4):911-912. PubMed ID: 28161225
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study.
    Kumada T; Toyoda H; Yasuda S; Tada T; Ogawa S; Takeshima K; Tanaka J; Chayama K; Johnson PJ
    Aliment Pharmacol Ther; 2020 Jul; 52(2):359-370. PubMed ID: 32519782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.
    Kurokawa K; Ohki T; Kato J; Fukumura Y; Imai M; Shibata C; Arai J; Kondo M; Takagi K; Kojima K; Seki M; Mori M; Toda N; Tagawa K
    J Med Case Rep; 2020 May; 14(1):62. PubMed ID: 32456712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N
    PLoS One; 2018; 13(3):e0194163. PubMed ID: 29534101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment.
    Kuo YH; Wang JH; Chang KC; Hung CH; Lu SN; Hu TH; Yen YH; Kee KM; Chen CH
    Invest New Drugs; 2020 Feb; 38(1):202-210. PubMed ID: 31701431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
    Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
    World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals.
    Hasson H; Merli M; Messina E; Bhoori S; Salpietro S; Morsica G; Regalia E; Bagaglio S; Lazzarin A; Uberti-Foppa C; Mazzaferro V
    J Hepatol; 2017 Aug; 67(2):415-417. PubMed ID: 28411040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis C virus infection and hepatocarcinogenesis].
    Berta E; Egresi A; Bacsárdi A; Gáspár Z; Lengyel G; Hagymási K
    Orv Hetil; 2019 Jun; 160(22):846-853. PubMed ID: 31131608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
    Li H; Huang MH; Jiang JD; Peng ZG
    World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.
    Sinn DH; Kang D; Hong YS; Koh KC; Guallar E; Cho J; Gwak GY
    PLoS One; 2021; 16(8):e0255624. PubMed ID: 34343200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
    Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.